106 related articles for article (PubMed ID: 10956388)
21. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
22. Sequence variants of DLC1 in colorectal and ovarian tumours.
Wilson PJ; McGlinn E; Marsh A; Evans T; Arnold J; Wright K; Biden K; Young J; Wainwright B; Wicking C; Chenevix-Trench G
Hum Mutat; 2000; 15(2):156-65. PubMed ID: 10649492
[TBL] [Abstract][Full Text] [Related]
23. Mutation analysis of the BRCA1 gene in ovarian cancers.
Takahashi H; Behbakht K; McGovern PE; Chiu HC; Couch FJ; Weber BL; Friedman LS; King MC; Furusato M; LiVolsi VA
Cancer Res; 1995 Jul; 55(14):2998-3002. PubMed ID: 7606717
[TBL] [Abstract][Full Text] [Related]
24. Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
Gad S; Teboul D; Lièvre A; Goasguen N; Berger A; Beaune P; Laurent-Puig P
BMC Cancer; 2004 Jul; 4():31. PubMed ID: 15245581
[TBL] [Abstract][Full Text] [Related]
25. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.
Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC
Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895
[TBL] [Abstract][Full Text] [Related]
26. Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.
Foster KA; Harrington P; Kerr J; Russell P; DiCioccio RA; Scott IV; Jacobs I; Chenevix-Trench G; Ponder BA; Gayther SA
Cancer Res; 1996 Aug; 56(16):3622-5. PubMed ID: 8705994
[TBL] [Abstract][Full Text] [Related]
27. Epithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression.
Sarhanis P; Redman C; Perrett C; Brannigan K; Clayton RN; Hand P; Musgrove C; Suarez V; Jones P; Fryer AA; Farrell WE; Strange RC
Br J Cancer; 1996 Dec; 74(11):1757-61. PubMed ID: 8956789
[TBL] [Abstract][Full Text] [Related]
28. Mutation analysis of EP300 in colon, breast and ovarian carcinomas.
Bryan EJ; Jokubaitis VJ; Chamberlain NL; Baxter SW; Dawson E; Choong DY; Campbell IG
Int J Cancer; 2002 Nov; 102(2):137-41. PubMed ID: 12385008
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.
Manderson EN; Birch AH; Shen Z; Mes-Masson AM; Provencher D; Tonin PN
Int J Gynecol Cancer; 2009 May; 19(4):513-25. PubMed ID: 19509545
[TBL] [Abstract][Full Text] [Related]
30. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q.
Kuroki T; Fujiwara Y; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y
Br J Cancer; 1995 Aug; 72(2):383-5. PubMed ID: 7640222
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
32. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.
Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y
Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800
[TBL] [Abstract][Full Text] [Related]
33. A protective role for common p21WAF1/Cip1 polymorphisms in human ovarian cancer.
Milner BJ; Brown I; Gabra H; Kitchener HC; Parkin DE; Haites NE
Int J Oncol; 1999 Jul; 15(1):117-9. PubMed ID: 10375603
[TBL] [Abstract][Full Text] [Related]
34. Molecular cloning, structural organization, sequence, chromosomal assignment, and expression of the mouse alpha-N-acetylgalactosaminidase gene.
Herrmann T; Schindler D; Tabe H; Onodera O; Igarashi S; Polack A; Zehnpfennig D; Shoji Tsuji
Gene; 1998 May; 211(2):205-14. PubMed ID: 9602128
[TBL] [Abstract][Full Text] [Related]
35. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
36. The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers.
Aberle H; Bierkamp C; Torchard D; Serova O; Wagner T; Natt E; Wirsching J; Heidkämper C; Montagna M; Lynch HT
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6384-8. PubMed ID: 7604000
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 mutations in primary breast and ovarian carcinomas.
Futreal PA; Liu Q; Shattuck-Eidens D; Cochran C; Harshman K; Tavtigian S; Bennett LM; Haugen-Strano A; Swensen J; Miki Y
Science; 1994 Oct; 266(5182):120-2. PubMed ID: 7939630
[TBL] [Abstract][Full Text] [Related]
38. Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers.
Williams LH; Choong D; Johnson SA; Campbell IG
Clin Cancer Res; 2006 Dec; 12(23):6967-72. PubMed ID: 17145815
[TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
[TBL] [Abstract][Full Text] [Related]
40. Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.
Jongsma AP; Piek JM; Zweemer RP; Verheijen RH; Klein Gebbinck JW; van Kamp GJ; Jacobs IJ; Shaw P; van Diest PJ; Kenemans P
Mol Pathol; 2002 Oct; 55(5):305-9. PubMed ID: 12354934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
